Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Projected Valuation Of The Peptide Synthesis Market In The Coming Years?
In recent years, the peptide synthesis market has experienced robust growth. The market, which is projected to expand from $5.69 billion in 2024 to $6.18 billion in 2025, will experience a compound annual growth rate (CAGR) of 8.6%. Factors such as the increase in peptide-based vaccines, development in biotechnology and biopharmaceutical sectors, high demand for high-purity peptides, as well as regulatory approvals and standardization, have contributed to the growth witnessed in the historic period.
The market for peptide synthesis is anticipated to experience significant expansion in the coming years. It is predicted to reach $8.92 billion in 2029, growing at a compound annual growth rate (CAGR) of 9.6%. Factors contributing to this projected growth during the forecast period are the fast-paced growth in therapeutic peptides, an escalated demand for customized peptides, their increasing role in drug discovery and development, and the emphasis on peptide libraries for screening. Key trends during the forecast period are expected to be the evolution of peptide mimetics, the embracing of new amino acid derivatives, techniques for peptide cyclization, advancements in solid-phase peptide synthesis (SPPs), and the application of click chemistry.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13295&type=smp
Which Growth Drivers Are Shaping The Peptide Synthesis Market Outlook?
The escalation in chronic illnesses is anticipated to fuel the expansion of the peptide synthesis market. Chronic illnesses, also known as non-communicable diseases (NCDs), are sustained health issues that last over a significant duration and typically develop slowly over time. Peptide synthesis can be utilized for these long-term diseases, given that some peptides exert both antioxidant and anti-inflammatory properties which could be instrumental in thwarting chronic illnesses, such as cardiovascular diseases. By targeting specific cellular processes and signaling pathways, peptides can address the core origins of chronic diseases, paving the way for new treatment and management options. For example, in June 2024, as per the Australian Institute of Health and Welfare, an Australia-based government entity, it was reported that in 2022, the age-standardized death ratio due to chronic conditions was 490 per 100,000 population, a significant increase from 459 per 100,000 in 2021. As such, the rising prevalence of chronic diseases is driving the expansion of the peptide synthesis market.
What Is The Segment Breakdown Of The Peptide Synthesis Market?
The peptide synthesismarket covered in this report is segmented –
1) By Product And Service: Reagents; Equipment; Services
2) By Technology: Solid-Phase Peptide Synthesis; Solution-Phase Peptide Synthesis; Hybrid And Recombinant Technology
3) By End User: Pharmaceutical And Biotechnology companies; Contract Manufacturing And Development Organizations (CDMOs) And Contract Research Organizations (CROs); Academic And Research Institutes
Subsegments:
1) By Reagents: Amino Acids; Coupling Reagents; Protecting Groups; Cleavage Reagents
2) By Equipment: Peptide Synthesizers; Chromatography Systems; Mass Spectrometers; Other Analytical Instruments
3) By Services: Custom Peptide Synthesis; Peptide Characterization And Analysis; Peptide Modification Services; Consulting And Support Services
What New Opportunities Are Emerging From Trends In The Peptide Synthesis Market?
Leading firms in the peptide synthesis sector are concentrating on launching cutting-edge peptide synthesizers, such as PurePep Sonata+, to stay ahead in the competitive market. Compared to conventional peptide synthesizers, PurePep Sonata+ is a more advanced version boasting enhanced effectiveness, swiftness, and precision. For example, Gyros Protein Technologies, a peptide synthesis and bioanalytical technology services company based in the United States, rolled out the PurePep Sonata+ peptide synthesizer in March 2022. The PurePep Sonata+ enhances the functionalities of the Sonata XT by incorporating real-time flow technology, a revolutionary method that facilitates continuous monitoring of the system’s fluid flow rates, thereby ensuring precise and accurate fluid transfers across a wide viscosity range.
Who Are The Major Stakeholders Operating In The Peptide Synthesis Market?
Major companies operating in the peptide synthesis market report are Thermo Fisher Scientific, Novo Nordisk A/S, Merck KGaA, Lonza Group, Kaneka Corporation, Uno Minda, Guizhou Xinbang Pharmaceutical Co. Ltd., Hybio Pharmaceutical Co. Ltd., GenScript Biotech, Bachem Holding AG, Syngene International, PolyPeptide Group AG, Mesa Labs Inc., CPC Scientific Inc., New England Peptide Inc., Biotage, ScinoPharm Taiwan Ltd., MP Biomedicals, USV Private Limited, CEM Corporation, Enamine Ltd., Creative Diagnostics, AnaSpec Inc., CSBio Company Inc., Alfa Chemistry, Advanced ChemTech, Gyros Protein Technologies AB, AAPPTec LLC, Biosynth International Inc., ProteoGenix
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/peptide-synthesis-global-market-report
Which Region Is Likely To Register The Fastest Growth In The Peptide Synthesis Market?
North America was the largest region in the peptide synthesis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=13295&type=smp
Browse Through More Reports Similar to the Global Peptide Synthesis Market 2025, By The Business Research Company
Peptide Antibiotics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report
Glycopeptide Antibiotics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/glycopeptide-antibiotics-global-market-report
Glucagon Like Peptide 1 Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/glucagon-like-peptide-1-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
